Beta-lapachone, a quinone isolated from Tabebuia avellanedae, induces apoptosis in HepG2 hepatoma cell line through induction of Bax and activation of caspase
Hyun Joo Woo et al. J Med Food. 2006 Summer.
Abstract
The DNA topoisomerase inhibitor beta-lapachone is a quinone obtained from the bark of the lapacho tree (Tabebuia avellanedae) in South America. It has been reported to possess a wide range of pharmacological properties, and is a promising cancer chemopreventive agent. In this study, the effects of beta-lapachone on the growth of the human hepatoma cell line HepG2 were investigated. The results showed that beta-lapachone inhibits the viability of HepG2 by inducing apoptosis, as evidenced by the formation of apoptotic bodies and DNA fragmentation. Reverse transcription-polymerase chain reaction and immunoblotting results indicated that treatments of cells with beta-lapachone resulted in down-regulation of anti-apoptotic Bcl-2 and Bcl-X(L) and up-regulation of pro-apoptotic Bax expression. beta-Lapachone-induced apoptosis was associated with a proteolytic activation of caspase-3 and -9 and degradation of poly(ADP-ribose) polymerase protein. However, beta-lapachone treatment did not affect the inhibitor of apoptosis proteins family and the Fas/FasL system. Taken together, our study indicated that beta-lapachone may have potential as a chemopreventive agent for liver cancer.
PubMed Disclaimer
Similar articles
- beta-lapachone induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2 family and activation of caspases. Lee JI, Choi DY, Chung HS, Seo HG, Woo HJ, Choi BT, Choi YH. Lee JI, et al. Exp Oncol. 2006 Mar;28(1):30-5. Exp Oncol. 2006. PMID: 16614704
- beta-Lapachone-induced apoptosis is associated with activation of caspase-3 and inactivation of NF-kappaB in human colon cancer HCT-116 cells. Choi BT, Cheong J, Choi YH. Choi BT, et al. Anticancer Drugs. 2003 Nov;14(10):845-50. doi: 10.1097/00001813-200311000-00011. Anticancer Drugs. 2003. PMID: 14597880
- Phosphorylation of p53, induction of Bax and activation of caspases during beta-lapachone-mediated apoptosis in human prostate epithelial cells. Choi YH, Kim MJ, Lee SY, Lee YN, Chi GY, Eom HS, Kim ND, Choi BT. Choi YH, et al. Int J Oncol. 2002 Dec;21(6):1293-9. Int J Oncol. 2002. PMID: 12429980
- A comprehensive review on β-lapachone: Mechanisms, structural modifications, and therapeutic potentials. Gong Q, Hu J, Wang P, Li X, Zhang X. Gong Q, et al. Eur J Med Chem. 2021 Jan 15;210:112962. doi: 10.1016/j.ejmech.2020.112962. Epub 2020 Oct 22. Eur J Med Chem. 2021. PMID: 33158575 Review.
- Lapachol and lapachone analogs: a journey of two decades of patent research(1997-2016). Hussain H, Green IR. Hussain H, et al. Expert Opin Ther Pat. 2017 Oct;27(10):1111-1121. doi: 10.1080/13543776.2017.1339792. Epub 2017 Jun 14. Expert Opin Ther Pat. 2017. PMID: 28586252 Review.
Cited by
- How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology? Kirdeeva Y, Fedorova O, Daks A, Barlev N, Shuvalov O. Kirdeeva Y, et al. Pharmaceuticals (Basel). 2022 Jul 14;15(7):868. doi: 10.3390/ph15070868. Pharmaceuticals (Basel). 2022. PMID: 35890166 Free PMC article. Review.
- Recent Advances and Challenges in Controlling the Spatiotemporal Release of Combinatorial Anticancer Drugs from Nanoparticles. Yoon MS, Lee YJ, Shin HJ, Park CW, Han SB, Jung JK, Kim JS, Shin DH. Yoon MS, et al. Pharmaceutics. 2020 Nov 27;12(12):1156. doi: 10.3390/pharmaceutics12121156. Pharmaceutics. 2020. PMID: 33261219 Free PMC article. Review.
- Tabebuia impetiginosa: A Comprehensive Review on Traditional Uses, Phytochemistry, and Immunopharmacological Properties. Zhang J, Hunto ST, Yang Y, Lee J, Cho JY. Zhang J, et al. Molecules. 2020 Sep 18;25(18):4294. doi: 10.3390/molecules25184294. Molecules. 2020. PMID: 32962180 Free PMC article. Review.
A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer.